Gain insights from provocative, frank and visionary panel discussions-no boring speeches or sales pitches!
Learn about the import and impact of the latest advancements in cancer research and treatments for patients, companies and payers
Access leading oncology innovators, industry executives and investors through Cancer Progress Partnering
Engineering the Future: Next Gen Platforms in Oncology
Daniel S. Chen, MD, PhD Chief Medical Officer
Tuesday, May 4, 2021 | 9:15 – 10:00 am EDT
Off-the-shelf CAR-engineered NK cells for the treatment of cancer
Katy Rezvani, MD, PhD Sally Copper Murray Endowed Chair in Cancer ResearchProfessor of Medicine, Chief, Section of Cellular Therapy,Director for Translational Research Medical Director, SCT Laboratory and the GMP Laboratory, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center